Hans-Georg Rammensee

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

Life Sciences, Immunology, Oncology +10

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 932 citations · Full text

Medicine, Biomedical Sciences, Oncology +12

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 784 citations

Medicine, Immunology, Oncology +17

Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Uwe D. Staerz, Hans-Georg Rammensee, J D Benedetto et al. · The Journal of Immunology · 1985 · 670 citations · Full text

Life Sciences, Cell Biology, Immunology +13

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 641 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14